Par Drugs and Chemicals Limited — Important, 13-11-2025: Updates
13-11-2025 | 04:49 pm
13-11-2025 | 04:49 pm
Par Drugs and Chemicals' Board approved Q2 & H1 financial results. Q2 revenue hit 28.66 Cr, with profit at 4.13 Cr. Half-year revenue soared to 54.71 Cr, but profit decreased YoY to 7.46 Cr, indicating margin pressure despite sales growth.
No comments yet. Be the first to comment!
